Purpose: The aim is to look at the impact of margin status and outcome of invasive lobular carcinoma (ILC) treated with breast-conserving therapy (BCT). Methods: This manuscript describes an analysis on 330 BCT in 318 patients with ILC. Results: The 12-year local relapse free survival (LRFS) is 89%. In multivariate analysis, positive mar,gin status, age > 50 years. contra lateral breast cancer, and adjuvant systemic therapy were significant predictors of local relapse free survival. In a separate analysis limited to a positive margin for invasive carcinoma or carcinoma in situ, only a positive margin for invasive carcinoma was a significant predictor of local relapse free survival. This was limited to women < 50 years. The 12-year disease-s...
Background Breast-conservation therapy (BCT), including wide local excision and postoperative irradi...
Previous studies of patients with breast cancer have compared survival of invasive ductal carcinoma ...
International audienceBACKGROUND:Invasive lobular carcinomas (ILCs) represent approximately 10% of a...
Purpose: The aim is to look at the impact of margin status and outcome of invasive lobular carcinoma...
PurposeThe aim is to look at the impact of margin status and outcome of invasive lobular carcinoma (...
Objective: We analyzed 382 patients with pure lobular carcinoma treated up to 2002 with sufficient f...
Background Invasive lobular breast carcinoma is known for its multicentricity and is associated with...
Background Invasive lobular breast carcinoma is known for its multicentricity and is associated with...
Background Invasive lobular breast carcinoma is known for its multicentricity and is associated with...
Background Invasive lobular breast carcinoma is known for its multicentricity and is associated with...
PURPOSE: To determine how patients with infiltrating lobular carcinoma (ILC) differ from patients wi...
BACKGROUND The goals of the current study were to compare the clinicopathologic presentations of pa...
Background: Invasive lobular carcinoma (ILC) comprises 8-15 % of all invasive breast cancers and lar...
Background: Invasive lobular carcinoma (ILC) comprises 8–15 % of all invasive breast cancers and lar...
Background: Invasive lobular carcinoma (ILC) comprises 8-15 % of all invasive breast cancers and lar...
Background Breast-conservation therapy (BCT), including wide local excision and postoperative irradi...
Previous studies of patients with breast cancer have compared survival of invasive ductal carcinoma ...
International audienceBACKGROUND:Invasive lobular carcinomas (ILCs) represent approximately 10% of a...
Purpose: The aim is to look at the impact of margin status and outcome of invasive lobular carcinoma...
PurposeThe aim is to look at the impact of margin status and outcome of invasive lobular carcinoma (...
Objective: We analyzed 382 patients with pure lobular carcinoma treated up to 2002 with sufficient f...
Background Invasive lobular breast carcinoma is known for its multicentricity and is associated with...
Background Invasive lobular breast carcinoma is known for its multicentricity and is associated with...
Background Invasive lobular breast carcinoma is known for its multicentricity and is associated with...
Background Invasive lobular breast carcinoma is known for its multicentricity and is associated with...
PURPOSE: To determine how patients with infiltrating lobular carcinoma (ILC) differ from patients wi...
BACKGROUND The goals of the current study were to compare the clinicopathologic presentations of pa...
Background: Invasive lobular carcinoma (ILC) comprises 8-15 % of all invasive breast cancers and lar...
Background: Invasive lobular carcinoma (ILC) comprises 8–15 % of all invasive breast cancers and lar...
Background: Invasive lobular carcinoma (ILC) comprises 8-15 % of all invasive breast cancers and lar...
Background Breast-conservation therapy (BCT), including wide local excision and postoperative irradi...
Previous studies of patients with breast cancer have compared survival of invasive ductal carcinoma ...
International audienceBACKGROUND:Invasive lobular carcinomas (ILCs) represent approximately 10% of a...